CT Appears to Be the Best First Strategy for Evaluating Stable Chest Pain

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

MONDAY, Feb. 5, 2024 -- A "computed tomography (CT)-first" strategy may be the best way to determine if stable chest pain patients need revascularization, according to a study presented at the American College of Cardiology Cardiovascular Summit 2024, which took place Feb. 1 to 3 in Washington, D.C.

William E. Downey, M.D., from Atrium Health Sanger Heart & Vascular Institute in Charlotte, North Carolina, and colleagues assessed whether a "CT-first" strategy versus functional testing or no testing is associated with higher rates of subsequent revascularization after invasive coronary angiography (ICA) in clinical practice. The analysis included 786 consecutive patients who had no prior diagnosis of coronary artery disease and were referred for elective ICA to evaluate chest pain.

The researchers found that the pre-ICA testing strategies included no testing in 44 percent, stress echo in 3 percent, stress myocardial perfusion imaging in 15 percent, stress magnetic resonance imaging in 2 percent, and coronary CT angiography in 36 percent. Subsequent revascularization occurred in 62 percent using the "CT-first" strategy versus 34 percent for other modalities.

"While care must be individualized, for patients with unknown or unestablished coronary artery disease, the transition to a 'CT-first' strategy should be a high priority for cardiovascular care providers," senior author Markus D. Scherer, M.D., also from the Sanger Heart & Vascular Institute, said in a statement. "The noninvasive approach has a lower risk and cost than a diagnostic heart catheterization and, for the CT approach -- but not stress testing -- provides information on the absence, presence, and extent of coronary atherosclerosis and whether or not there are high risk plaques as well as vessel blockages, which helps streamline patient management and risk reduction.”

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-02-06 00:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords